PUMA SE (PMMAF) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of PUMA SE $11.53, price $23.60, upside -51.1%, quality 40 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? No
- Good quality? No
- Add to watchlist
PUMA SE
PMMAF · USWeakest SetupStrongly overvalued and low quality.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.
How to read this chart
60‑month range $18.07 – $118.69 · fair‑value band $5.90 – $17.13 · the $23.60 price screens above the $11.53 fair value. Dashed = 300-day average. As of Oct 2, 2026.
Company profile
PUMA SE, together with its subsidiaries, engages in the development and sale of sports and sports lifestyle products in Europe, Middle East, Africa, India, North America, Latin America, Greater China, Rest of Asia-Pacific, and internationally.
Show more
PUMA SE, together with its subsidiaries, engages in the development and sale of sports and sports lifestyle products in Europe, Middle East, Africa, India, North America, Latin America, Greater China, Rest of Asia-Pacific, and internationally. It offers sports lifestyle products for football, handball, rugby, cricket, volleyball, track and field, motor sports, golf, and basketball. The company also issues licenses to independent partners to design, develop, manufacture, and sell glasses, safety shoes, workwear, and gaming accessories. It sells its products under the PUMA and Cobra Golf brands through retail stores, factory outlets, and online stores, as well as wholesale and retail trade. PUMA SE was founded in 1919 and is headquartered in Herzogenaurach, Germany.
Stock analysis
PUMA SE (PMMAF) currently trades at $23.60, while our model-based Fair Value estimate is $11.53, 51.1% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Dividend Discount group reads highest at a median of $10.39 per share, and 0 of the 4 models we run sit above the $23.60 price.
Bear case: the Multiples group reads lowest at $7.61, and 4 of the 4 models stay below the price. Evidence for this calculation is low.
Scenario range: $5.90 (bear) to $17.13 (bull), the price of $23.60 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 40/100 (below-average quality), in the Consumer Cyclical sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
PUMA SE reported revenue of €7.3B in FY2025 versus €6.8B in FY2021, a compound +1.7%/yr. Reported net income was −€643M in FY2025.
Key figures
Market cap $5.0B · P/S ratio 0.70 · EPS (TTM) $−4.86 · Dividend yield 1.8% · Net margin −8.8% · Return on equity −27.3% · Return on assets (EBIT) 6.3% · Operating margin 3.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 30% below its 52-week high and 31% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at 110% fair-value upside, at −51%, PMMAF screens richer than that median.
Fair Value models
All 4 models by family
Notify me when PMMAF reaches fair value
Put PMMAF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Of which business quality 39 · Market factors (momentum, volatility) 32
Revenue & earnings trend
PMMAF screens overvalued: fair value 51% below the price. Compare with NIKE, Inc →
Recent news
- Puma opens U.S. distribution centers to third parties
- Interparfums’ Long-Term Puma and Cavalli Fragrance Deals Could Be A Game Changer For IPAR
- Puma Biotechnology Initiates ALISCA®-Lung2, a Phase II Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with
- Is PUMA (XTRA:PUM) Undervalued Following Its Leadership Change?
Compare PUMA SE with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Footwear & Accessories · 91 stocks
Valuation Multiplesvs Footwear & Accessories median · lower = cheaper
Context: sector, industry, market
- Is the Consumer Discretionary sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Footwear & Accessories stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| NIKE, Inc NKE | $35.15 | $34.38 | −2% |
| Deckers Outdoor Corporation DECK | $78.36 | $176.31 | +125% |
| On Holding ONON | $29.96 | $26.80 | −11% |
| Zhejiang China Commodities City Group 600415 | ¥10.84 | ¥27.10 | +150% |
| Crocs, Inc CROX | $122.63 | $281.25 | +129% |
| Huali Industrial Group 300979 | ¥34.18 | ¥50.95 | +49% |
| Birkenstock Holding BIRK | $33.60 | $50.10 | +49% |
| Steven Madden, Ltd SHOO | $44.90 | $12.34 | −73% |
| Yue Yuen Industrial (Holdings) Limited 0551 | HK$12.60 | HK$31.67 | +151% |
| Pou Chen Corporation 9904 | 24.85 TWD | 52.19 TWD | +110% |
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is PUMA SE (PMMAF) overvalued or undervalued?
What is the fair value of PMMAF?
What is the quality score of PMMAF?
What is the price target for PUMA SE (PMMAF)?
What is the PUMA SE stock forecast for 2026?
What is the revenue of PUMA SE (PMMAF)?
Does PUMA SE pay a dividend?
What is the intrinsic value of PUMA SE (PMMAF)?
Is PUMA SE stock overvalued or undervalued in 2026?
Is fair value the same as the market price of PMMAF?
How much is PUMA SE worth?
What do the bullish and bearish scenarios say about PMMAF?
What is the PEG ratio of PMMAF?
How solid is the balance sheet of PUMA SE (PMMAF)?
How far is PMMAF from its 52-week high?
Which stocks are comparable to PUMA SE?
Is PUMA SE stock attractive at the current price?
How is the fair value of PMMAF calculated?
Is it still worth investing in stocks now?
What is the share price of PUMA SE (PMMAF)?
What should I pay attention to with PUMA SE right now?
Where does the earnings growth of PUMA SE (PMMAF) come from?
Key figures of PUMA SE
How large is the market capitalisation of PUMA SE (PMMAF)?
What is the P/S ratio of PUMA SE (PMMAF)?
What are the earnings per share of PUMA SE (PMMAF)?
What is the dividend yield of PUMA SE (PMMAF)?
What is the net margin of PUMA SE (PMMAF)?
What is the return on equity of PUMA SE (PMMAF)?
What is the EBIT return on assets of PUMA SE (PMMAF)?
What is the operating margin of PUMA SE (PMMAF)?
How fast is revenue growing at PUMA SE (PMMAF)?
How fast are earnings growing at PUMA SE (PMMAF)?
How much free cash flow does PUMA SE (PMMAF) generate?
How much net debt does PUMA SE (PMMAF) carry?
Watch PUMA SE in the live analysis
One click puts PUMA SE on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.